Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $10.2K invested in Revelation Biosciences Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
16,377% more capital inflows, than outflows
Capital inflows: $2.14K | Capital outflows: $13
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12 |
| 2 |
Clear Street
New York
|
-$1 |
REVBW Hedge Fund Activity: Q4 2025 in Review
11 of the 8,299 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2025, worth a combined $10.2K — down 21% from $13K a quarter earlier.
Fund positioning in REVBW was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3. The largest seller was UBS Group, exiting entirely with an estimated $12 sold.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $10.2K of Revelation Biosciences Warrant stock for Q4 2025, down 21% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2025 was Citadel Advisors, an estimated $3 added.
- The largest Revelation Biosciences Warrant seller in Q4 2025 was UBS Group, an estimated $12 sold.
Based on aggregated 13F filings for Q4 2025.